title: Rofecoxib-induced cholestatic hepatitis: treatment with molecular adsorbent recycling system (MARS).
authors.forename: Dominik
authors.initials: D
authors.lastname: Huster
authors.forename: Christian
authors.initials: C
authors.lastname: Schubert
authors.forename: Frieder
authors.initials: F
authors.lastname: Berr
authors.forename: Joachim
authors.initials: J
authors.lastname: Mössner
authors.forename: Karel
authors.initials: K
authors.lastname: Caca
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002779:Cholestasis / Q000139:chemically induced* / Q000628:therapy*; D005260:Female; D006505:Hepatitis / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D019164:Liver, Artificial; D008875:Middle Aged; D016060:Sorption Detoxification; D013450:Sulfones
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib